多发伤患者血清高迁移率族蛋白B1及可溶性髓样细胞触发受体-1水平变化及预后意义
|
|
王桂杰, 杜传冲, 陆叶, 赵健, 沈勰, 金冬林, 耿佳财
|
Changes of serum high mobility group box 1 and soluble triggering receptor expressed on myeloid cells-1 in patients with multiple injuries and their prognostic significance
|
|
WANG Guijie, DU Chuanchong, LU Ye, ZHAO Jian, SHEN Xie, JIN Donglin, GENG Jiacai
|
|
表3 存活组和死亡组基本资料比较
|
Tab 3 Comparison of basic data between the survival group and the death group
|
|
| Variable | Survival group (n=79) | Death group (n=13) | t/χ2 value | P value |
|---|
| Age/year | 42.53±11.64 | 47.31±11.71 | 1.369 | 0.174 | | Gender/n(%) | | | 0.837 | 0.546 | | Male | 44 (55.70) | 9 (69.23) | | | | Female | 35 (40.30) | 4 (30.77) | | | | Background disease/n(%) | | | 0.387 | 0.747 | | Yes | 25 (31.65) | 3 (23.08) | | | | No | 54 (68.35) | 10 (76.92) | | | | Admission time/h | 4.43±0.92 | 5.00±0.51 | 3.259 | 0.003 | | Injury factor/n(%) | | | 1.224 | 0.570 | | Transportation | 54 (68.35) | 8 (61.54) | | | | Fall accident from high place | 19 (24.05) | 3 (23.08) | | | | Other | 6 (7.59) | 2 (15.38) | | | | Number of wound sites/n | 2.66±0.64 | 2.92±0.49 | 1.425 | 0.158 | | Primary trauma site/n(%) | | | 7.400 | 0.042 | | Head | 32 (40.51) | 11 (84.62) | | | | Chest | 27 (34.18) | 1 (7.69) | | | | Abdomen | 14 (17.72) | 1 (7.69) | | | | Limbs and pelvis | 6 (7.59) | 0 (0) | | | | Emergency operation/n(%) | | | 2.391 | 0.181 | | Yes | 20 (25.32) | 6 (46.15) | | | | No | 59 (74.68) | 7 (53.85) | | | | Massive transfusion/n(%) | | | 4.778 | 0.055 | | Yes | 24 (34.18) | 8 (61.54) | | | | No | 55 (65.82) | 5 (38.46) | | | | Severity/n(%) | | | 19.475 | 0.000 | | Lightly injury | 22 (27.85) | 2 (15.38) | | | | Gravely injury | 54 (68.35) | 4 (30.77) | | | | Severe injury | 3 (3.80) | 7 (53.85) | | | | GCS score/score | 10.31±2.04 | 9.51±2.27 | 1.286 | 0.202 | | APTT/s | 30.31±5.02 | 32.97±5.91 | 1.727 | 0.088 | | DD/(mg·L-1) | 0.81±0.37 | 0.89±0.29 | 0.770 | 0.443 | | MODS/n(%) | | | 5.304 | 0.032 | | Yes | 14 (17.72) | 6 (46.15) | | | | No | 65 (82.28) | 7 (53.85) | | | | hs-CRP/(mg·L-1) | 18.74±3.98 | 21.79±3.28 | 2.612 | 0.011 | | IL-6/(pg·mL-1) | 65.16±14.11 | 78.33±10.46 | 3.215 | 0.002 | | PCT/(ng·mL-1) | 4.06±0.90 | 5.02±0.91 | 3.560 | 0.001 |
|
|
|